Two studies presented in March at #ACC19 are the talk of the cardiology community. Both address one question: Can low-risk patients with aortic stenosis benefit from TAVR? Dharam Kumbhani, M.D., says the data are intriguing, but the excitement is a bit premature. Learn more.
VSD, or ventricular septal defect, is a complication in 1/1,000 patients who don't get ER care for a heart attack – and 97% die within a year of suffering this complication. This procedure is the last chance to save their lives.
